Arvinas Appoints Ronald Peck Chief Medical Officer

Ronald Peck has been appointed chief medical officer of New Haven, CT-based Arvinas (NASDAQ: [[ticker:ARVN]]). Peck most recently worked at cancer drug developer Tesaro where he was senior vice president of clinical research. His experience also includes posts at Kolltan Pharmaceuticals and Bristol-Myers Squibb (NYSE: [[ticker:BMY]]). Arvinas is developing drugs based on protein degradation, a cellular process for disposing of harmful proteins. In June, the company began a multi-year partnership with Bayer to develop products for both human health and agriculture.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.